Encompass Health Corporation Common Stock (EHC)
119.00
+0.37 (0.31%)
NYSE · Last Trade: Aug 13th, 4:06 PM EDT
Detailed Quote
Previous Close | 118.63 |
---|---|
Open | 119.19 |
Bid | 118.95 |
Ask | 119.00 |
Day's Range | 118.50 - 119.61 |
52 Week Range | 85.55 - 123.13 |
Volume | 418,051 |
Market Cap | 11.84B |
PE Ratio (TTM) | 23.29 |
EPS (TTM) | 5.1 |
Dividend & Yield | 0.6800 (0.57%) |
1 Month Average Volume | 1,144,650 |
Chart
About Encompass Health Corporation Common Stock (EHC)
Encompass Health Corp is a leading provider of integrated healthcare services, specializing in post-acute care through its extensive network of inpatient rehabilitation hospitals, home health agencies, and hospice services. The company focuses on delivering high-quality care and rehabilitation to patients recovering from serious illnesses and injuries, such as strokes or orthopedic surgeries, enhancing their overall health outcomes and quality of life. Through its commitment to innovative care models and comprehensive treatment plans, Encompass Health aims to meet the diverse needs of patients and foster a holistic approach to rehabilitation and recovery. Read More
News & Press Releases
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 13, 2025
Let’s dig into the relative performance of Encompass Health (NYSE:EHC) and its peers as we unravel the now-completed Q2 outpatient & specialty care earnings season.
Via StockStory · August 13, 2025
Health care services provider Encompass Health (NYSE:EHC) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 12% year on year to $1.46 billion. The company’s full-year revenue guidance of $5.93 billion at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $1.40 per share was 15.8% above analysts’ consensus estimates.
Via StockStory · August 12, 2025
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 9, 2025
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Encompass (EHC) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · August 6, 2025
Check out these five stocks that are beating the market in 2025 and just announced dividend increases of between 10% and 15%.
Via MarketBeat · August 6, 2025
Via Benzinga · August 6, 2025
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 5, 2025
Encompass Health (EHC) beat Q2 2025 earnings estimates with $1.46B revenue and $1.40 EPS, raising full-year guidance. Stock surged 3.38% post-announcement.
Via Chartmill · August 4, 2025
Health care services provider Encompass Health (NYSE:EHC)
will be announcing earnings results this Monday afternoon. Here’s what you need to know.
Via StockStory · August 2, 2025
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 1, 2025
Via Benzinga · July 30, 2025
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Encompass (EHC) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · July 29, 2025
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Via StockStory · July 29, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · July 28, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Encompass Health (NYSE:EHC) and its peers.
Via StockStory · July 27, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Encompass (EHC), National Grid (NGG), or Quantum (QMCO) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · July 23, 2025
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · July 23, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · July 21, 2025
RADNOR, PA - July 21, 2025 ( NEWMEDIAWIRE ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) is currently investigating potential violations of the federal securities laws on behalf of investors of Encompass Health Corporation ( NYSE: EHC ) (“Encompass Health”).
Via TheNewswire.com · July 21, 2025
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass Health” or “the Company”) (NYSE: EHC) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · July 18, 2025
RADNOR, PA - July 18, 2025 ( NEWMEDIAWIRE ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) is currently investigating potential violations of the federal securities laws on behalf of investors of Encompass Health Corporation ( NYSE: EHC ) (“Encompass Health”).
Via TheNewswire.com · July 18, 2025